Literature DB >> 20824906

Lenalidomide for bortezomib-resistant multiple myeloma.

Chiara Briani, Tamara Berno, Marta Campagnolo, Renato Zambello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20824906     DOI： 10.1038/nrclinonc.2010.31-c1

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  6 in total

1.  Renal recovery with lenalidomide in a patient with bortezomib-resistant multiple myeloma.

Authors:  Heinz Ludwig; Niklas Zojer
Journal:  Nat Rev Clin Oncol       Date:  2010-03-30       Impact factor: 66.675

Review 2.  Lenalidomide: a novel anticancer drug with multiple modalities.

Authors:  Christine Galustian; Angus Dalgleish
Journal:  Expert Opin Pharmacother       Date:  2009-01       Impact factor: 3.889

3.  Myeloma-associated polyneuropathy responding to lenalidomide.

Authors:  Robert Layzer; Jeffrey Wolf
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

Review 4.  Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.

Authors:  Ashraf Badros; Olga Goloubeva; Jay S Dalal; Ilyas Can; Jennifer Thompson; Aaron P Rapoport; Meyer Heyman; Gorgon Akpek; Robert G Fenton
Journal:  Cancer       Date:  2007-09-01       Impact factor: 6.860

5.  The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.

Authors:  Guido Cavaletti; Barbara Frigeni; Francesca Lanzani; Marialuisa Piatti; Stefania Rota; Chiara Briani; Gabriella Zara; Rosaria Plasmati; Francesca Pastorelli; Augusto Caraceni; Andrea Pace; Mariagrazia Manicone; Andrea Lissoni; Nicoletta Colombo; Giulia Bianchi; Claudio Zanna
Journal:  J Peripher Nerv Syst       Date:  2007-09       Impact factor: 3.494

6.  Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus.

Authors:  C Briani; G Zara; R Rondinone; S Della Libera; M Ermani; S Ruggero; A Ghirardello; S Zampieri; A Doria
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910
  6 in total
  2 in total

1.  Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients.

Authors:  Chiara Briani; Andrea Visentin; Alessandro Salvalaggio; Silvia Imbergamo; Francesco Piazza; Mario Cacciavillani; Marta Campagnolo; Federica Frezzato; Gianpietro Semenzato; Livio Trentin
Journal:  Haematologica       Date:  2016-12-07       Impact factor: 9.941

2.  Downregulation of MicroRNA-152 contributes to high expression of DKK1 in multiple myeloma.

Authors:  Yinyin Xu; Bingda Chen; Suraj K George; Beizhong Liu
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.